Blue-chip stocks are from companies that are large, well-established, and financially sound. These companies have strong ...

Pro Medicus shares are trading at a 240% premium to our fair value. Pro Medicus’ strategy revolves around renewing existing ...

Compounders tend to deliver steadier, more durable profit growth across full cycles, making them better suited for long-term ...

Woodside is guiding for a 7%-14% decline in 2026 production to 172-186mmboe, with major second-quarter maintenance for Pluto ...

Warsh has criticized Powell and advocated for lower interest rates, but analysts are comfortable with his nomination.

We are no longer able to provide Gainers and Losers data for constituents of S&P Australia and NZ indexes. We apologise for any inconvenience. Morningstar Investor clients please sign in here.

Investors are looking past prior fears of U.S. tariffs or concerns of an artificial intelligence bubble, which bodes well for ...

Coming up: Third-quarter guidance is largely in line with expectations, although it is officially slightly better than our ...

How Morningstar’s APAC Chief Investment Officer Matt Wacher is approaching 2026.

The ASX ( ASX: ASX) released unaudited results for the first half of fiscal 2026 and updated near-term expense guidance.

From cloud computing growth to AI monetization, here’s what we’re looking for in Alphabet’s upcoming earnings report.

The bottom line: We raise our fair value estimate for narrow-moat Tesla to $400 from $300. The primary drivers are a higher ...